You should pay more attention tomorrow for Gilead's PDUFA date ( SOF/VEL ). A yes vote coupled with the sick IBB would send this Putrid of a stock down the the 6s.
Flapper Steven never learns to keep quiet!LOL. Open Mouth and the stock went from the 9s to where it is. You also have the Triple Crown Flapping a.biopharma.....A Dunce Hats Lover!!!!
Volume always preceeded price change. Positive = Good News on the Horizon. Negative then you know why.
Yeap Flappers Steven and Dunce Hats wearer a.knownothingaboutbiopharm never learn past lessons from Magpie. Every time Flappers open their mouth, they got a mouthful of Foot. Amazing Negative Money Flow for this stock. A huge negative of -10.12 Million on 3,245,144. More pain to come.
How many times you have me on Ignore!LMAO. You bet this post will be sticky for a long time. "Peak' 'Peek" or 'Climpse' meme chose. Peak here described the maximum HCV RNA Reduction. You still don't get.
Multiple ascending dose from 400 to 800 mg in GT1. Following 7 days of dosing with 800 mg, the Maximum mean reduction in HCV RNA in subject with GT1 was ~3.5 log reduction. Comparable with Ach_3422. A weak NUC to say the least. Another Dud!
you do realize Gilead has a PDUFA date for Sofosbuvir/Velpatasvir; all Gynotypes on June 25th of this month.
Priority Review by the FDA. You can count on another nod by the Agency and that would be the end of Dream Chasers. By 2020, a full course treatment for HCV patients will be around 20k or less. Desh knows dawn well thus pocket the money and run.
It's not a question of 'If' but 'when' WDC announces another 10 to 20,000 layoffs; the stock will jump to 60 easily. I coudn't even phantom the 3 combined companies, WDC, SNDK and Hitachi would have over 80,000 people worldwide. This is a Huge burden to the bottom line and need to be trimmed asap.
Tell me that dose escalating from previous phases up to 400 mg of AL-335 were ineffective. History of NUC development, a maximum dosage of 400 mg combined with other direct acting agents deemed Safe. Janssen needs to be careful to use dosage as high as 800 mg. Toxicities would be a Real Issue.
This is exactly what I want. If I am to be a WDC shareholder after the merger. I may as well own the stock at a much lower price and ride it back up. Can't say the same for the longs here.
It's because the merger with WDC is structured as 67.50 in cash and .2387 share of Western Digital. So the factor now is how high can WDC go. Frankly I prefer the 86.50 cash per share plus the 0.027 share of WDC.